Case Report: Chlamydia psittaci pneumonia complicated by Guillain-Barré syndrome detected using metagenomic next-generation sequencing

Front Cell Infect Microbiol. 2023 Jan 23:12:1070760. doi: 10.3389/fcimb.2022.1070760. eCollection 2022.

Abstract

Psittacosis and Guillain-Barré syndrome are both rare clinical diseases with low incidence, and their combination has rarely been reported. Here, we report a case of Chlamydia psittaci pneumonia combined with Guillain-Barré syndrome. The patient initially presented with high fever, difficulty breathing, and fatigue. Chest computerised tomography indicated large consolidation opacities in both lungs. Metagenomic next-generation sequencing clearly identified the pathogen as C. psittaci. The patient's fever subsided after targeted antibiotic treatment, but difficulty breathing and fatigue worsened, and the patient developed symmetric limb numbness and weakness. Lumbar puncture, electrophysiological examination, and clinical characteristics were suggestive of Guillain-Barré syndrome, and the symptoms improved after treatment with human immunoglobulin. The results of this study suggest that metagenomic next-generation sequencing is useful for the rapid diagnosis of pulmonary infectious agents. Psittacosis is closely associated with the development of Guillain-Barré syndrome; however, more cases are needed to support this conclusion, and early targeted antibiotic treatment, immunotherapy, and basic supportive treatment are essential for improving outcomes.

Keywords: Guillain-Barre syndrome; antibiotic therapy; chlamydia psittaci pneumonia; metagenomic next-generation sequencing; psittacosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Chlamydophila psittaci* / genetics
  • Fatigue / complications
  • Guillain-Barre Syndrome* / complications
  • Guillain-Barre Syndrome* / diagnosis
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Pneumonia* / complications
  • Psittacosis* / complications
  • Psittacosis* / diagnosis

Substances

  • Anti-Bacterial Agents

Grants and funding

This study was supported by the Science and Technology Special Project of Huizhou (Grant no. 2020Y105).